Affiner les résultats

Impact of variable CYP genotypes on breast cancer relapse in patients undergoing adjuvant tamoxifen therapy

Mwinyi, Jessica ; Vokinger, Kerstin ; Jetter, Alexander ; Breitenstein, Urs ; Hiller, Christian ; Kullak-Ublick, Gerd ; Trojan, Andreas

In: Cancer Chemotherapy and Pharmacology, 2014, vol. 73, no. 6, p. 1181-1188

Caring for a loved one with a malignant fungating wound

Probst, Sebastian ; Arber, Anne ; Trojan, Andreas ; Faithfull, Sara

In: Supportive Care in Cancer, 2012, vol. 20, no. 12, p. 3065-3070

Bevacizumab specifically decreases elevated levels of circulating KIT+CD11b+ cells and IL-10 in metastatic breast cancer patients

Cattin, Sarah ; Fellay, Benoît ; Pradervand, Sylvain ; Trojan, Andreas ; Ruhstaller, Thomas ; Rüegg, Curzio ; Fürstenberger, Gregor

In: Oncotarget, 2016, vol. 7, no. 10, p. 11137–11150

Whether bevacizumab exerts its anti-tumor properties through systemic effects beyond local inhibition of angiogenesis and how these effects can be monitored in patients, remain largely elusive. To address these questions, we investigated bone marrow-derived cells and cytokines in the peripheral blood of metastatic breast cancer patients undergoing therapy with...